Mumbai, June 30 -- Mumbai-based Aequitas Healthcare is an eight-year-old pharmaceutical company engaged primarily in the sale of pharmaceutical products to hospitals. The company reported a turnover of Rs 53.31 crore in FY26.

The proposed acquisition is aligned with the company's long-term vision of strengthening its presence in India's growing healthcare ecosystem.

The total consideration would be Rs 20.8 crore, which shall be funded from internal accruals of Jagsonpal. The current directors of Aequitas shall retain 15% stake and shall continue to be associated with the business.

The transaction is subject to the fulfilment of customary closing conditions, and expected to be concluded by 15th July, 2026.

Manish Gupta, managing direct...